Masimo Corporation (MASI)
| Market Cap | 13.86B |
| Revenue (ttm) | 1.14B |
| Net Income (ttm) | 240.30M |
| Shares Out | 54.70M |
| EPS (ttm) | 4.14 |
| PE Ratio | 60.56 |
| Forward PE | 59.52 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $250.73 |
| Previous Close | $246.11 |
| Change ($) | 4.62 |
| Change (%) | 1.88% |
| Day's Open | 247.09 |
| Day's Range | 244.96 - 251.76 |
| Day's Volume | 397,960 |
| 52-Week Range | 143.90 - 284.86 |
Masimo (MASI) continues to gain from its key Product segment, which witnessed solid growth in Q4.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Raymond James 42nd Annual Institutional Investors Conference on We...
Shares of Masimo (NASDAQ:MASI) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 7.69% year over year to $0.98, which beat the...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 2, 2021. Fourth Quarter 2020 Results: Total reve...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo softFlow®, innovative high-flow nasal cannula therapy, is now available in the U.S. for spontaneously breathing adult patients.
Masimo Corporation (MASI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.
Masimo (MASI) SafetyNet-OPEN aids organizations in detecting those who are most vulnerable to COVID-19.
IRVINE, Calif.--(BUSINESS WIRE)--As previously announced on January 13, Masimo (NASDAQ: MASI) will release fourth quarter and full year 2020 financial results for the period ended January 2, 2...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo SafetyNet-OPEN™, a web and mobile app solution that helps organizations stay open safely during COVID-19 and beyond, has full market release.
Latest study favors Medtronic's (MDT) Nellcor Pulse Oximetry for all newborns considered for study, unlike from those newborns with Masimo's oximeter.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the BTIG MedTech and Digital Health Conference on Thursday, February 1...
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo has successfully completed the acquisition of LiDCO, a leading provider of advanced hemodynamic monitoring systems.
BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and p...
Masimo's (MASI) iSirona helps in efficient workflow in hospitals by providing continuous connectivity, thereby helping clinicians to improve patient outcomes.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo announced iSirona™, a compact, versatile, connectivity hub that routes data from medical devices to the Masimo Hospital Automation™ platform.
Per the preliminary announcement, Masimo (MASI) projects 2020 product revenues to improve.
The booming digital health space has been witnessing significant M&A activities amid the pandemic.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial and operational results for the full-year ended January 2, 2021 and provided est...
Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo is helping Renown Health address the COVID-19 surge, in part through use of Masimo SafetyNet™, a remote patient management solution.
Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study used Masimo ORi™, Oxygen Reserve Index, to help limit the extent of postoperative hyperoxia.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--In a study of pediatric patients, Masimo SpHb® was associated with improved outcomes, including reduced postoperative transfusion and ICU stays.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo was featured at CLSA's Pantheon 2020 conference for its efforts to help clinicians and hospitals combat COVID-19.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on Wednesday, December...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study of mechanically ventilated patients compared Masimo PVi® to another noninvasive fluid responsiveness indicator and found PVi advantageous.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A cancer study using a PBM program with Masimo SpHb® found decreased RBC units transfused per patient and increased transfusion appropriateness.
IRVINE, Calif.--(BUSINESS WIRE)--Joe Kiani, Founder & CEO of Masimo & co-inventor of measure-through-motion pulse oximetry, was honored by SIBEN for improvements to neonatal health.
There are many useful nooks and crannies on the GuruFocus website, including screeners that help us find stocks outside the mainstream.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo Radius VSM™, a versatile, expandable, wearable, tetherless vital signs monitor, has received CE marking and limited market release in Europe.
Masimo (MASI) continues to gain from key Product segment, which witnessed solid growth in Q3.
Masimo Corporation (MASI) CEO Joe Kiani on Q3 2020 Results - Earnings Call Transcript
Masimo (MASI) delivered earnings and revenue surprises of 42.86% and 1.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the third quarter ended September 26, 2020. Third Quarter 2020 Results: Total revenue, includin...
Masimo is trading near a potential buy area ahead of its next quarterly earnings report, expected on or around Oct. 27. The post Masimo Near Later-Stage Buy Point Ahead Of Earnings Report appe...
Masimo (MASI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2020 financial results for the period ended September 26, 2020, after the market closes on Tuesday, October 27...
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Masimo is near a buy zone with earnings due on or around Oct. 27. The post Highly Rated Masimo Forms Later-Stage Base With Earnings Due appeared first on Investor's Business Daily.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--In an ASA abstract, researchers investigated whether Masimo ORi™ could predict the need for postoperative oxygen therapy in children with sleep apnea.
Masimo's (MASI) wearable wireless continuous thermometer offers consumers hassle-free continuous body temperature measurements, thereby eliminating the need for manual measurements.
Masimo, a maker medical devices that include a Covid-19 monitor, finally gave its first 2020 guidance and also posted preliminary third-quarter sales that beat expectation; MASI stock rose. Th...
According to the All-in-One Screener, a Premium feature of GuruFocus, five stalwarts that have high financial strength and expanding operating margins include Mastech Digital Inc. (MHH), Colum...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the third quarter ended September 26, 2020, and provided select fina...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo is launching the wearable, wireless Radius Tº™ Continuous Thermometer for consumers.
New Historical Data Screen identifies stocks with high returns over the past 5 years
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Rad-G™, which provides spot-checking and continuous monitoring with SET® pulse oximetry and other parameters, has received FDA clearance.
About MASI
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen satura... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Aug 8, 2007 |
| CEO Joseph Kiani | Employees 2,000 |
| Stock Exchange NASDAQ | Ticker Symbol MASI |
Financial Performance
In 2020, Masimo's revenue was $1.14 billion, an increase of 21.96% compared to the previous year's $937.84 million. Earnings were $240.30 million, an increase of 22.47%.
Analyst Forecasts
According to 9 analysts, the average rating for Masimo stock is "Buy." The 12-month stock price forecast is 297.83, which is an increase of 18.79% from the latest price.